Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 22.01.16 in Vol 5, No 1 (2016): Jan-Mar

This paper is in the following e-collection/theme issue:

Works citing "Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.4830):

(note that this is only a small subset of citations)

  1. Rowe C, Santos G, Raymond HF, Coffin PO. Social mixing and correlates of injection frequency among opioid use partnerships. International Journal of Drug Policy 2017;41:80
  2. Rockstroh JK, Yazdanpanah Y. HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?. Journal of Antimicrobial Chemotherapy 2019;74(Supplement_5):v2
  3. Hochstatter KR, Gustafson Sr DH, Landucci G, Pe-Romashko K, Maus A, Shah DV, Taylor QA, Gill EK, Miller R, Krechel S, Westergaard RP. A Mobile Health Intervention to Improve Hepatitis C Outcomes Among People With Opioid Use Disorder: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2019;8(8):e12620
  4. Hochstatter KR, Hull SJ, Sethi AK, Burns ME, Mundt MP, Westergaard RP. Promoting safe injection practices, substance use reduction, hepatitis C testing, and overdose prevention among syringe service program clients using a computer-tailored intervention: A pilot randomized controlled trial (Preprint). Journal of Medical Internet Research 2020;
  5. Hochstatter KR, Hull SJ, Stockman LJ, Stephens LK, Olson-Streed HK, Ehlenbach WJ, Repplinger MD, Jacobs EA, Westergaard RP. Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: Experience from a pilot intervention. International Journal of Drug Policy 2017;42:22
  6. Rossi C, Butt ZA, Wong S, Buxton JA, Islam N, Yu A, Darvishian M, Gilbert M, Wong J, Chapinal N, Binka M, Alvarez M, Tyndall MW, Krajden M, Janjua NZ. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort. Journal of Hepatology 2018;69(5):1007